Employing a click chemistry approach we have synthesized a novel triazole-linked cationic porphyrin-β-carboline conjugate which exhibited remarkable photocytotoxicity against the A549 cancer cell line (IC(50) = 60 nM).

Download full-text PDF

Source
http://dx.doi.org/10.1039/c2cc38018hDOI Listing

Publication Analysis

Top Keywords

remarkable photocytotoxicity
8
novel triazole-linked
8
triazole-linked cationic
8
cationic porphyrin-β-carboline
8
porphyrin-β-carboline conjugate
8
photocytotoxicity novel
4
conjugate employing
4
employing click
4
click chemistry
4
chemistry approach
4

Similar Publications

Phthalocyanine aggregates as semiconductor-like photocatalysts for hypoxic-tumor photodynamic immunotherapy.

Nat Commun

January 2025

Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, China.

Photodynamic immunotherapy (PIT) has emerged as a promising approach for efficient eradication of primary tumors and inhibition of tumor metastasis. However, most of photosensitizers (PSs) for PIT exhibit notable oxygen dependence. Herein, a concept emphasizing on transition from molecular PSs into semiconductor-like photocatalysts is proposed, which converts the PSs from type II photoreaction to efficient type I photoreaction.

View Article and Find Full Text PDF

The Photodynamic Agent Designed by Involvement of Hydrogen Atom Transfer for Enhancing Photodynamic Therapy.

Angew Chem Int Ed Engl

January 2025

Institution Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, P. R. China.

Article Synopsis
  • Type-I photodynamic therapy shows promise due to its lower oxygen dependency, but creating effective photosensitizers is challenging.
  • A new photosensitizer was developed that utilizes hydrogen atom transfer (HAT) and can produce both superoxide and carbon-centered radicals when exposed to light.
  • This novel photosensitizer, tested in mouse models with HeLa tumors, demonstrated high photocytotoxicity and effective antitumor results, indicating a promising design strategy for future Type-I photosensitizers.
View Article and Find Full Text PDF

The development of new and improved mitochondria-targeting photosensitisers (PSs) for photodynamic therapy (PDT) remains highly desirable, due to the critical role the mitochondria play in maintaining healthy cellular function. Here, we report the design, synthesis, photophysical properties and biological characterisation of a series of di-iodinated BODIPY-based PSs, BODIPY-Mito-I-n, for mitochondria-targeted PDT applications. Six BODIPY-Mito-I-n analogues were synthesised in good yields, with fast reaction times of between 30 and 60 min under mild conditions.

View Article and Find Full Text PDF

Cross-linking strategies have found wide applications in chemical biology, enabling the labeling of biomolecules and monitoring of protein-protein interactions. Nitrone exhibits remarkable versatility and applicability in bioorthogonal labeling due to its high reactivity with strained alkynes via the strain-promoted alkyne-nitrone cycloaddition (SPANC) reaction. In this work, four cyclometalated iridium(III) polypyridine complexes functionalized with two nitrone units were designed as novel phosphorogenic bioorthogonal reagents for bioimaging and phototherapeutics.

View Article and Find Full Text PDF

As the field of preclinical research on photosensitizers (PSs) for anticancer photodynamic therapy (PDT) continues to expand, a focused effort is underway to develop agents with innovative molecular structures that offer enhanced targeting, selectivity, activation, and imaging capabilities. In this context, we introduce two new heavy-atom-free PSs, DBXI and DBAI, characterized by a twisted π-conjugation framework. This innovative approach enhances the spin-orbit coupling (SOC) between the singlet excited state (S) and the triplet state (T), resulting in improved and efficient intersystem crossing (ISC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!